MAR 19, 2014 12:00 PM PDT

Chemogenetics: a transformational technology for neuroscience

Presented At Neuroscience
162 56 3658

  • Michael Hooker Distinguished Professor, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy
      Bryan L. Roth MD, PhD is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Chapel Hill School of Medicine. Dr. Roth received his MD and PhD (Biochemistry) from St. Louis University in 1983 and subsequently training in pharmacology (NIH), molecular biology and psychiatry (Stanford) . Dr. Roth has published more than 400 papers in the general area of the molecular pharmacology of drug actions, including a large number of papers published in Science, Nature and Cell over the past decade. Dr. Roth has more than 40 patents and has founded 2 companies. Dr. Roth has been elected to the National Academy of Medicine of the National Academy of Sciences and has received many honors including the Goodman and Gilman Award for Receptor Pharmacology (ASPET; 2016), the PhRMA Foundation Excellence in Pharmacology Award, and a NARSAD Distinguished Investigator Award. Dr. Roth also given many endowed lectures including the Goodman, Koppyani, Strongwater, Niznik, Swammerdam, Lowenthal, S.G. Fergusson, Chauncy Leake and Philip S. Portoghese Lectures. Dr. Roth has also been named the 2018 IUHPAR Lecturer in Analytical Pharmacology (IUPHAR), the 2017 Martin S. Rodbell Lecturer and the inaugural 2017 Elliot Saul Vessell Visiting Professor. Dr. Roth has also been named a Thompson Reuters 'Highly Cited Scientist' in Pharmacology and in Biology and Biochemistry.


    Show Resources
    Loading Comments...